This is the EMF Channel database of light therapy study doses. After getting the results, click to view more study details. Only successful studies are included. 99% of the studies here are on humans, not animals. This database is a work in progress. Many thanks to Vlad for his PBM database. When the data here references his work, the detail page includes a link to the PBM spreadsheet.
Significant Gulf War Illness (Chronic Multisymptom Illness) Improvements after 12 Weeks of Vielight Neuro Alpha Treatment
Improvements in Gulf War Illness Symptoms After Near-Infrared
Transcranial and Intranasal Photobiomodulation: Two Case
Researchers tested the effects of the Vielight Neuro Alpha photobiomodulation device on Gulf War Illness (GWI) symptoms. GWI symptoms include persistent headaches, cognitive difficulties, joint pain, musculoskeletal pain, fatigue, gastrointestinal problems. Because the pattern can present in non-Gulf War veterans, the phenomenon is also called Chronic Multisymptom Illness (CMI). A CMI diagnosis is 6 months of symptoms in at least two of these categories: fatigue, pain, and cognitive-mood. A Kansas GWI is moderately severe or multiple chronic symptoms in at least three of these categories: fatigue/sleep problems, pain, neurological/
cognitive/mood problems, respiratory problems, gastrointestinal problems, and skin problems.
Subjects took self-assessment questionnaires and cognitive tests. They tested before treatment and at the 12-week mark. Gulf War Veteran 1 (GWV1) presented as a Kansas GI. Gulf War Veteran 2 (GWV2) presented as Kansas GWI. Subjects used the Vielight Neuro Alpha device daily for 12 weeks. The device delivers:
- 810 nm 100 mW/cm^2 pulsed at 10 Hz to 3 posterior transcranial targets
- 810 nm 75 mW/cm^2 pulsed at 10 Hz to an anterior target
- 810 nm 25 mW/cm^2 pulsed at 10 Hz to an intranasal passage
At 12 weeks both subjects improved on multiple scores. GWV1 no longer qualified as Kansas GWI. He was re-categorized as mild-moderate CMI. GWV1 showed improvements in mood-cognitive, pain, sleep and fatique categories.
GWV2 was re-categorized from severe CMI to mild-moderate CMI. He showed improvements in fatique, pain and mood-cognitive scores.
Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness: Case-control Study with a Pair of Identical Twins.
Reduce muscle damage, muscle pain (soreness), muscle atrophy, muscle recovery time; increase muscle mass, and athletic performance treating the quadriceps femoris muscles with 850 nm LED light with a total of 75 J.
Low-Level Laser Therapy Effectiveness for Reducing Pain after Breast Augmentation
Reduce surgical pain by 37%.
The Effect of Light-Emitting Diode (590/830 Nm)-Based Low-Level Laser Therapy on Posttraumatic Edema of Facial Bone Fracture Patients
16.5% edema reduction in LLLT group compared to 7.3% in sham group.
Lasertherapy efficacy in temporomandibular disorders: control study.
Decrease TMJ pain and increase jaw movement.
Evaluation of low-level laser therapy in the treatment of temporomandibular disorders.
Improve TMJ mouth opening range, decrease pain, chewing difficulty, and tenderness.
The effect of low-level laser in knee osteoarthritis: a double-blind, randomized, placebo-controlled trial.
Improve knee osteoarthritis pain, flexion, pressure, sensitivity, and circumference.
Efficacy of different therapy regimes of low‐power laser in painful osteoarthritis of the knee: A double‐blind and randomized‐controlled trial
Reduce knee osteoarthritis pain.
Improvement of Pain and Disability in Elderly Patients with Degenerative Osteoarthritis of the Knee Treated with Narrow‐Band Light Therapy
Reduce geriatric degenerative osteoarthritis pain.
Photobiomodulation via a Cluster Device Associated With a Physical Exercise Program in the Level of Pain and Muscle Strength in Middle-Aged and Older Women With Knee Osteoarthritis: A Randomized Placebo-Controlled Trial
Reduce knee arthritis pain and inflammation.
Incorporation of Photobiomodulation Therapy Into a Therapeutic Exercise Program for Knee Osteoarthritis: A Placebo-Controlled, Randomized, Clinical Trial
Reduce knee osteoarthritis pain.
Can Photobiomodulation Associated With Implantation of Mesenchymal Adipose-Derived Stem Cells Attenuate the Expression of MMPs and Decrease Degradation of Type II Collagen in an Experimental Model of Osteoarthritis?
Prevent knee arthritis inflammation and degeneration.
Effect of Light-Emitting Diodes Therapy (LEDT) on Knee Extensor Muscle Fatigue
Reduce post-exercise loss of function.
TREATMENT OF POST HERPETIC NEURALGIA USING A 904 nm (INFRARED) LOW INCIDENT ENERGY LASER: A CLINICAL STUDY
Reduce post-herpetic neuralgia pain from from 8.54/10 to 0-3/10.
Early Application of Low-Level Laser May Reduce the Incidence of Postherpetic Neuralgia (PHN)
Prevent post-herpetic neuralgia: “Applying LLLT within the first 5 days of herpes zoster eruption significantly reduced the incidence of PHN.”
LLLT: low level light therapy
PHN: post-herpetic neuralgia
Role of Low-Level Laser Therapy in Post-Herpetic Neuralgia: A Pilot Study
Reduce shingles pain from severe to severe/moderate/mild with no remissions for at least “several months.”
Low-intensity Laser Therapy Is an Effective Treatment for Recurrent Herpes Simplex Infection. Results From a Randomized Double-Blind Placebo-Controlled Study
Increase time to recurrence of herpes outbreak.
The Effectiveness of Conservative Treatments of Carpal Tunnel Syndrome: Splinting, Ultrasound, and Low-Level Laser Therapies
Decrease carpal tunnel pain.
Comparison of the Long-Term Effectiveness of Physiotherapy Programs With Low-Level Laser Therapy and Pulsed Magnetic Field in Patients With Carpal Tunnel Syndrome
Decrease carpal tunnel pain.
A Case Control Series for the Effect of Photobiomodulation in Patients With Low Back Pain and Concurrent Depression
Reduce back pain and depression.
About the EMF Channel Light Dose Database
Many people purchase red light therapy or neuromuscular electrical stimulation devices without knowing optimal doses for the results they want to see. The right dose is especially key to light therapies, which have optimal windows of wavelength and energy delivered. Treatment doses outside of those windows will nullify results or harm the user. I took the results from successful EMF studies when these studies included:
- Photobiomodulation (Red Light Therapy, Blue Light Therapy, Low Level Light Therapy)
- Transcutaneous Electromagnetic Nerve Stimulation (TENS)
- Pulsed Electromagnetic Field (PEMF) Therapy
- Neuromuscular Electrical Stimulation (NMES)
Many studies do not report exact dose parameters they used. They are therefore not included here, even the study reported a therapeutic result.
Source: Turchin, Curtis. Light and Laser Therapy: Clinical Procedures 6th Edition (p. 16)